tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ADXS Stock Latest News

OS Therapies to acquire listeria programs from Ayala Pharmaceuticals
The FlyOS Therapies to acquire listeria programs from Ayala Pharmaceuticals
19h ago
ADXS
OSTX
Advaxis Executive Reshuffle Following Asset Sale
PremiumCompany Announcements
Advaxis Executive Reshuffle Following Asset Sale
10M ago
8K
ADXS
Immunome price target raised to $33 from $27 at Wedbush
PremiumThe Fly
Immunome price target raised to $33 from $27 at Wedbush
10M ago
ADXS
IMNM
Advaxis Enhances Operations Through Strategic Asset Sale
PremiumCompany Announcements
Advaxis Enhances Operations Through Strategic Asset Sale
10M ago
8K
ADXS
Ayala Pharmaceuticals completes sale of AL102 to Immunome
PremiumThe Fly
Ayala Pharmaceuticals completes sale of AL102 to Immunome
10M ago
ADXS
IMNM
Advaxis Clarifies CMO Bonus Terms Amid Asset Sale
PremiumCompany AnnouncementsAdvaxis Clarifies CMO Bonus Terms Amid Asset Sale
11M ago
8K
ADXS
Advaxis Asset Sale Approved by Majority Shareholder Vote
Premium
Company Announcements
Advaxis Asset Sale Approved by Majority Shareholder Vote
12M ago
8K
ADXS
Advaxis Executes Strategic Unregistered Equity Sales
Premium
Company Announcements
Advaxis Executes Strategic Unregistered Equity Sales
12M ago
8K
ADXS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
12M ago
EQ
ADXS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
12M ago
EQ
MOR
Advaxis Explores Future Post Asset Purchase Agreement
PremiumCompany Announcements
Advaxis Explores Future Post Asset Purchase Agreement
12M ago
8K
ADXS
Advaxis Executives Secure Bonuses After Asset Purchase
PremiumCompany Announcements
Advaxis Executives Secure Bonuses After Asset Purchase
12M ago
8K
ADXS
Advaxis Announces Definitive Agreement with Ayala Pharmaceuticals
PremiumCompany AnnouncementsAdvaxis Announces Definitive Agreement with Ayala Pharmaceuticals
12M ago
8K
ADXS
Immunome to acquire AL102 from Ayala for $20M in cash, $30M in stock
Premium
The Fly
Immunome to acquire AL102 from Ayala for $20M in cash, $30M in stock
12M ago
ADXS
IMNM
Ayala Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
Premium
The Fly
Ayala Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
1y ago
ADXS
Ayala Pharmaceuticals receives Orphan Drug Designation for AL102
PremiumThe Fly
Ayala Pharmaceuticals receives Orphan Drug Designation for AL102
1y ago
ADXS
Ayala Pharmaceuticals treatment of desmoid tumors granted orphan designation
PremiumThe Fly
Ayala Pharmaceuticals treatment of desmoid tumors granted orphan designation
1y ago
ADXS
Ayala Pharmaceuticals presents updated AL102 results at ESMO congress
PremiumThe Fly
Ayala Pharmaceuticals presents updated AL102 results at ESMO congress
1y ago
ADXS
Ayala Pharmaceuticals closes merger with Biosight
PremiumThe Fly
Ayala Pharmaceuticals closes merger with Biosight
1y ago
ADXS
Ayala Pharmaceuticals, Biosight enter definitive merger agreement
PremiumThe FlyAyala Pharmaceuticals, Biosight enter definitive merger agreement
2y ago
ADXS
Ayala announces End-of-Phase 2 meeting with FDA on AL102 in desmoid tumors
Premium
The Fly
Ayala announces End-of-Phase 2 meeting with FDA on AL102 in desmoid tumors
2y ago
ADXS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
ADXS
IOVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >